Healthtech Solutions Inc. (HLTT)

$0.27

-0.04 (-12.90%)
Rating:
Recommendation:
-
Symbol HLTT
Price $0.27
Beta 4.770
Volume Avg. 0.01M
Market Cap 18.891M
Shares () -
52 Week Range 0.101-0.65
1y Target Est -
DCF Unlevered HLTT DCF ->
DCF Levered HLTT LDCF ->
ROE 47151653.75% Strong Buy
ROA -237272714.95% Strong Sell
Operating Margin -
Debt / Equity -191.84% Sell
P/E 13.50 Strong Buy
P/B -7.77 Strong Sell
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades


Healthcare
Health Information Services
Other OTC

Healthtech Solutions, Inc., through its subsidiaries, operates as a life sciences company. It focuses on the development of wound care products for acute and chronic wounds, including AmnioBind, a placental membrane allograft for burns and non-healing wounds, such as diabetic foot ulcers. The company also engages in the development of ultrasound imaging and artificial intelligence-based image analysis software for the applications in treatment of chest and musculoskeletal system. In addition, it is developing software technology that compares a healthy heart rhythm electronic signal with a damaged heart's signal that derives an electronic signal representing the curative waveform. The company was founded in 2018 and is based in Tuckahoe, New York.